We just received data on a new analyst forecast for $CB. JMP Securities gave a rating of 'Market Outperform' for $CB.
$CB Analyst Ratings
Wall Street analysts have issued reports on $CB in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- JMP Securities issued a "Market Outperform" rating on 10/22/2025
- Evercore ISI Group issued a "Outperform" rating on 10/01/2025
- Keefe, Bruyette & Woods issued a "Outperform" rating on 07/09/2025
To track analyst ratings and price targets for $CB, check out Quiver Quantitative's $CB forecast page.
$CB Price Targets
Multiple analysts have issued price targets for $CB recently. We have seen 13 analysts offer price targets for $CB in the last 6 months, with a median target of $310.0.
Here are some recent targets:
- Matthew J. Carletti from JMP Securities set a target price of $325.0 on 10/22/2025
- Jimmy Bhullar from JP Morgan set a target price of $327.0 on 10/09/2025
- Elyse Greenspan from Wells Fargo set a target price of $277.0 on 10/08/2025
- Alex Scott from Barclays set a target price of $310.0 on 10/08/2025
- David Motemaden from Evercore ISI Group set a target price of $315.0 on 10/01/2025
- Tracy Benguigui from Wolfe Research set a target price of $320.0 on 09/16/2025
- Bob Huang from Morgan Stanley set a target price of $295.0 on 08/18/2025
$CB Congressional Stock Trading
Members of Congress have traded $CB stock 4 times in the past 6 months. Of those trades, 1 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $CB stock by members of Congress over the last 6 months:
- SENATOR SHELLEY MOORE CAPITO sold up to $15,000 on 07/17.
- REPRESENTATIVE JOSH GOTTHEIMER purchased up to $15,000 on 06/13.
- REPRESENTATIVE ROBERT BRESNAHAN sold up to $15,000 on 06/13.
- REPRESENTATIVE JEFFERSON SHREVE sold up to $50,000 on 05/12.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$CB Insider Trading Activity
$CB insiders have traded $CB stock on the open market 11 times in the past 6 months. Of those trades, 2 have been purchases and 9 have been sales.
Here’s a breakdown of recent trading of $CB stock by insiders over the last 6 months:
- JOHN W KEOGH (President & COO) has made 1 purchase buying 9,809 shares for an estimated $2,874,135 and 4 sales selling 94,876 shares for an estimated $27,563,599.
- JUAN LUIS ORTEGA (Executive Vice President*) sold 6,504 shares for an estimated $1,900,013
- JOHN J LUPICA (Vice Chrm, Chubb Group*) has made 0 purchases and 2 sales selling 5,513 shares for an estimated $1,599,077.
- JOSEPH F WAYLAND (Executive Vice President and*) sold 5,261 shares for an estimated $1,542,314
- MICHAEL G ATIEH sold 538 shares for an estimated $154,707
- MICHAEL CORBAT purchased 425 shares for an estimated $114,665
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CB Hedge Fund Activity
We have seen 931 institutional investors add shares of $CB stock to their portfolio, and 773 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- DEMARS FINANCIAL GROUP, LLC removed 6,232,723 shares (-99.9%) from their portfolio in Q2 2025, for an estimated $1,805,744,507
- CAPITAL RESEARCH GLOBAL INVESTORS removed 2,640,770 shares (-28.4%) from their portfolio in Q2 2025, for an estimated $765,083,884
- VIKING GLOBAL INVESTORS LP removed 1,949,065 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $564,683,111
- FMR LLC removed 1,020,172 shares (-6.8%) from their portfolio in Q2 2025, for an estimated $295,564,231
- WELLINGTON MANAGEMENT GROUP LLP added 991,889 shares (+13.8%) to their portfolio in Q2 2025, for an estimated $287,370,081
- TWO SIGMA INVESTMENTS, LP added 767,626 shares (+13234.9%) to their portfolio in Q2 2025, for an estimated $222,396,604
- FIRST TRUST ADVISORS LP removed 537,938 shares (-29.6%) from their portfolio in Q2 2025, for an estimated $155,851,397
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
